Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
WNbFc 36
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
mAB 4-8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
T cells
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
GS‐441524
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/19/2021
WNbFc 15
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
mAB 2-17
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
CoV-X2
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/25/2021
WNbFc 7
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
Plerixafor
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
mAB 4-18
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
Temsirolimus
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021
ACE2‐TMPRSS2‐EVs
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/28/2020
TPNT1
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/22/2021
S-FL-opt/S1 recombinant protein
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/08/2021
P2B-2F6
Potential treatment - pre-clinical evidence Experimental Antiviral May/26/2020
WNbFc 2
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
Silymarin
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/05/2021
mAB 5-24
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021
Everolimus
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021
FN3D
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021